|
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time
07/16/2025
|
|
|
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes
06/04/2025
|
|
|
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement
05/21/2025
|
|
|
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement
05/15/2025
|
|
|
Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement
05/15/2025
|
|
|
Senseonics Holdings, Inc. Reports First Quarter Financial Results
05/08/2025
|
|
|
Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time
04/29/2025
|
|
|
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
04/29/2025
|
|
|
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
03/03/2025
|
|
|
Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care
02/26/2025
|
|